Sign Up to like & get
recommendations!
1
Published in 2019 at "Diabetes"
DOI: 10.2337/db19-115-lb
Abstract: The time needed to reliably assess closed-loop performance in adults with sub-optimal glucose control (A1c 59 to 86 mmol/mol) including changes in behavioral adaptation is currently unknown. We combined data from 2 multi-national randomized closed-loop…
read more here.
Keywords:
closed loop;
self abbott;
inc;
novo nordisk ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Diabetes"
DOI: 10.2337/db20-100-lb
Abstract: Closed Loop Control (CLC) has the ability to reduce both hypoglycemia and hyperglycemia. We conducted a post-hoc analysis of data from the iDCL DCLP3 randomized trial comparing CLC with Control-IQ versus sensor augmented pump therapy…
read more here.
Keywords:
diabetes care;
hypoglycemia;
self dexcom;
tandem diabetes ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Diabetes"
DOI: 10.2337/db20-17-lb
Abstract: Pregnancies in type 1 diabetes (T1D) are high-risk, and data in the U.S. are limited regarding clinical and CGM based hypoglycemia throughout pregnancy while on sensor augmented insulin pump (SAP). Pregnant women with T1D on…
read more here.
Keywords:
research support;
diabetes care;
support self;
dexcom inc ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Diabetes"
DOI: 10.2337/db20-174-or
Abstract: A BIA was performed comparing clinical cost offsets for rt-CGM compared with SMBG for U.S. Medicaid enrollees with type 1 diabetes (T1D) over one year. Clinical effects for HbA1c reduction using rt-CGM (-1.0%) and SMBG…
read more here.
Keywords:
smbg;
cgm;
smbg medicaid;
medicaid enrollees ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Diabetes"
DOI: 10.2337/db20-345-or
Abstract: The Omnipod Horizon™ System is a hybrid closed-loop system (HCL) consisting of a tubeless insulin pump and Dexcom G6 sensor which provides automated insulin delivery with customizable glucose targets from 110-150mg/dL, adjustable by time of…
read more here.
Keywords:
system;
corporation;
pharmaceuticals inc;
self ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Diabetes"
DOI: 10.2337/db20-980-p
Abstract: Glycemic control during and after exercise is challenging. APs reduce % 30min, between 4-7pm. During SH, participants used either a naive AP (CTL) or exercise informed AP (EX) and participated in 45min of moderate exercise…
read more here.
Keywords:
system;
diabetes care;
self dexcom;
tandem diabetes ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Diabetes"
DOI: 10.2337/db21-622-p
Abstract: Real-time continuous glucose monitoring (CGM) systems allow users to take immediate action based on current glucose and its trajectory; retrospective review of CGM data permits behavior modification according to historic trends. Dexcom CGM Systems allow…
read more here.
Keywords:
cgm data;
time;
cgm;
engagement ... See more keywords